Danaher Co. (NYSE:DHR) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC trimmed its stake in shares of Danaher Co. (NYSE:DHR) by 4.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 167,187 shares of the conglomerate’s stock after selling 8,698 shares during the period. MetLife Investment Management LLC’s holdings in Danaher were worth $46,481,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher in the second quarter valued at $25,000. nVerses Capital LLC acquired a new stake in Danaher in the 2nd quarter valued at about $25,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher during the 3rd quarter valued at about $40,000. MFA Wealth Advisors LLC acquired a new position in Danaher during the second quarter worth about $51,000. Finally, Financial Connections Group Inc. purchased a new stake in shares of Danaher in the second quarter valued at about $51,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. TD Cowen lifted their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective on the stock. UBS Group decreased their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Barclays cut their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Finally, Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Trading Up 0.9 %

Shares of NYSE DHR traded up $2.15 during midday trading on Wednesday, hitting $238.73. The stock had a trading volume of 108,442 shares, compared to its average volume of 2,755,117. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The company has a market capitalization of $172.43 billion, a price-to-earnings ratio of 45.14, a PEG ratio of 4.37 and a beta of 0.85. The company has a fifty day moving average price of $256.66 and a 200 day moving average price of $259.81.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the previous year, the company posted $2.02 earnings per share. Danaher’s revenue was up 3.1% compared to the same quarter last year. On average, analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.